Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia

We report that combination bNAb immunotherapy initiated on day 3 post-infection (PI) maintained durable CD8(+) T cell–mediated suppression of SHIV(AD8) viremia and preinoculation levels of CD4(+) T cells in 9 of 13 treated monkeys during nearly 6 yr of observation, as assessed by successive CD8(+) T...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Yoshiaki, Donau, Olivia K., Dias, Joana, Ferrando-Martinez, Sara, Jesteadt, Eric, Sadjadpour, Reza, Gautam, Rajeev, Buckler-White, Alicia, Geleziunas, Romas, Koup, Richard A., Nussenzweig, Michel C., Martin, Malcolm A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953630/
https://www.ncbi.nlm.nih.gov/pubmed/32966579
http://dx.doi.org/10.1084/jem.20201214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953630/
https://www.ncbi.nlm.nih.gov/pubmed/32966579
http://dx.doi.org/10.1084/jem.20201214

Ejemplares similares